Coronary microcirculation assessment using functional angiography: Development of a wire-free method applicable to conventional coronary angiograms.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
15 11 2021
Historique:
revised: 01 06 2021
received: 23 02 2021
accepted: 18 06 2021
pubmed: 10 7 2021
medline: 15 12 2021
entrez: 9 7 2021
Statut: ppublish

Résumé

We aimed to develop a novel wire- and adenosine-free microcirculatory resistive index from functional angiography (angio-IMR) to estimate coronary microcirculatory resistance, and to investigate how this method can improve clinical interpretation of physiological stenosis assessment with quantitative flow ratio (QFR). Hyperemic index of coronary microcirculatory resistance (IMR) is a widely used tool to assess microcirculatory dysfunction. However, the need of dedicated intracoronary wire and hyperemia limits its adoption in clinical practice. We performed our study in two separate stages: (1) development of a formula (angio-IMR) to estimate IMR from resting angiograms and aortic pressure (Pa), and (2) validation of the method in a clinical population using invasively measured IMR as reference. Additionally, QFR diagnostic performance was assessed considering angio-IMR values. We developed the formula: angio-IMR = (Pa-[0.1*Pa])*QFR*e-Tmn (where e-Tmn is an estimation of hyperaemic mean transit time) and validated it in 115 vessels (104 patients). Angio-IMR correlated well with IMR (Spearman's rho = 0.70, p < 0.001). Sensitivity, specificity, positive and negative predictive value, accuracy and area under the curve of angio-IMR to predict IMR were 87.5% (73.2-95.8), 85.3% (75.3-92.4), 76.1% (64.5-84.8), 92.8% (84.9-96.7), 85% and 0.90 (0.83-0.95), respectively. False positive QFR measurements decreased from 19.5% to 8.5% when angio-IMR was incorporated into the QFR interpretation workflow. Estimation of IMR without physiology wire and adenosine is feasible. Coronary microcirculatory dysfunction causing high IMR can be ruled-out with high confidence in vessels with low angio-IMR. Awareness of angio-IMR contributes to a better clinical interpretation of functional stenosis assessment with QFR.

Sections du résumé

OBJECTIVES
We aimed to develop a novel wire- and adenosine-free microcirculatory resistive index from functional angiography (angio-IMR) to estimate coronary microcirculatory resistance, and to investigate how this method can improve clinical interpretation of physiological stenosis assessment with quantitative flow ratio (QFR).
BACKGROUND
Hyperemic index of coronary microcirculatory resistance (IMR) is a widely used tool to assess microcirculatory dysfunction. However, the need of dedicated intracoronary wire and hyperemia limits its adoption in clinical practice.
METHODS
We performed our study in two separate stages: (1) development of a formula (angio-IMR) to estimate IMR from resting angiograms and aortic pressure (Pa), and (2) validation of the method in a clinical population using invasively measured IMR as reference. Additionally, QFR diagnostic performance was assessed considering angio-IMR values.
RESULTS
We developed the formula: angio-IMR = (Pa-[0.1*Pa])*QFR*e-Tmn (where e-Tmn is an estimation of hyperaemic mean transit time) and validated it in 115 vessels (104 patients). Angio-IMR correlated well with IMR (Spearman's rho = 0.70, p < 0.001). Sensitivity, specificity, positive and negative predictive value, accuracy and area under the curve of angio-IMR to predict IMR were 87.5% (73.2-95.8), 85.3% (75.3-92.4), 76.1% (64.5-84.8), 92.8% (84.9-96.7), 85% and 0.90 (0.83-0.95), respectively. False positive QFR measurements decreased from 19.5% to 8.5% when angio-IMR was incorporated into the QFR interpretation workflow.
CONCLUSIONS
Estimation of IMR without physiology wire and adenosine is feasible. Coronary microcirculatory dysfunction causing high IMR can be ruled-out with high confidence in vessels with low angio-IMR. Awareness of angio-IMR contributes to a better clinical interpretation of functional stenosis assessment with QFR.

Identifiants

pubmed: 34242489
doi: 10.1002/ccd.29863
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1027-1037

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35:1101-1111.
Knuuti J, Wijns W, Saraste A, et al. ESC scientific document group. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407-477.
Fearon WF, Balsam LB, Farouque HMO, et al. Novel index for invasively assessing the coronary microcirculation. Circulation. 2003;107:3129-3132.
Echavarria-Pinto M, Escaned J, Macías E, et al. Disturbed coronary hemodynamics in vessels with intermediate stenoses evaluated with fractional flow reserve: a combined analysis of epicardial and microcirculatory involvement in ischemic heart disease. Circulation. 2013;128:2557-2566.
Fearon WF, Low AF, Yong AS, et al. Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention. Circulation. 2013;127:2436-2441.
Ahn SG, Hung OY, Lee J-W, et al. Combination of the thermodilution-derived index of microcirculatory resistance and coronary flow reserve is highly predictive of microvascular obstruction on cardiac magnetic resonance imaging after ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2016;9:793-801.
McGeoch R, Watkins S, Berry C, et al. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2010;3:715-722.
Nishi T, Murai T, Ciccarelli G, et al. Prognostic value of coronary microvascular function measured immediately after percutaneous coronary intervention in stable coronary artery disease: an international Multicenter study. Circ Cardiovasc Interv. 2019;12:e007889.
Nishi T, Kitahara H, Saito Y, et al. Invasive assessment of microvascular function in patients with valvular heart disease. Coron Artery Dis. 2018;29:223-229.
Kim H-S, Tremmel JA, Nam C-W, et al. Quantitative comparison of microcirculatory dysfunction in patients with stress cardiomyopathy and ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2011;58:2430-2431.
Fearon WF, Hirohata A, Nakamura M, et al. Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: physiologic investigation for transplant arteriopathy II (PITA II) study. J Heart Lung Transplant. 2006;25:765-771.
Ford TJ, Stanley B, Good R, et al. Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial. J Am Coll Cardiol. 2018;72:2841-2855.
Morris PD, van de Vosse FN, Lawford PV, Hose DR, Gunn JP. 'Virtual' (computed) fractional flow reserve: current challenges and Limitations. JACC Cardiovasc Interv. 2015;8:1009-1017.
Mejía-Rentería H, Lee JM, Lauri F, et al. Influence of microcirculatory dysfunction on angiography-based functional assessment of coronary stenoses. JACC Cardiovasc Interv. 2018;11:741-753.
Kanno Y, Hoshino M, Hamaya R, et al. Functional classification discordance in intermediate coronary stenoses between fractional flow reserve and angiography-based quantitative flow ratio. Open Heart. 2020;7:e001179.
Tu S, Westra J, Yang J, et al. Diagnostic accuracy of fast computational approaches to derive fractional flow reserve from diagnostic coronary angiography: the international Multicenter FAVOR pilot study. JACC Cardiovasc Interv. 2016;9:2024-2035.
Mejía-Rentería H, Lauri FM, Lee JM, et al. Interindividual variations in the adenosine-induced Hemodynamics during fractional flow reserve evaluation: implications for the use of quantitative flow ratio in assessing intermediate coronary stenoses. J Am Heart Assoc. 2019;8:e012906.
Lee JM, Jung J-H, Hwang D, et al. Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis. J Am Coll Cardiol. 2016;67:1158-1169.
Hamaya R, Yonetsu T, Kanaji Y, et al. Diagnostic and prognostic efficacy of coronary flow capacity obtained using pressure-temperature sensor-tipped wire-derived physiological indices. JACC Cardiovasc Interv. 2018;11:728-737.
Yong AS, Layland J, Fearon WF, et al. Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis. JACC Cardiovasc Interv. 2013;6:53-58.
Kunadian V, Chieffo A, Camici PG, et al. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by coronary vasomotor disorders international study group. Eur Heart J. 2020;41:3504-3520.
Echavarría-Pinto M, Gonzalo N, Ibañez B, et al. Low coronary microcirculatory resistance associated with profound hypotension during intravenous adenosine infusion: implications for the functional assessment of coronary stenoses. Circ Cardiovasc Interv. 2014;7:35-42.
Siebes M, Chamuleau SAJ, Meuwissen M, Piek JJ, Spaan JAE. Influence of hemodynamic conditions on fractional flow reserve: parametric analysis of underlying model. Am J Physiol Heart Circ Physiol. 2002;283:H1462-H1470.
Lee JM, Layland J, Jung J-H, et al. Integrated physiologic assessment of ischemic heart disease in real-world practice using index of microcirculatory resistance and fractional flow reserve: insights from the international index of microcirculatory resistance registry. Circ Cardiovasc Interv. 2015;8:e002857.
Echavarría-Pinto M, van de Hoef TP, Nijjer S, et al. Influence of the amount of myocardium subtended to a coronary stenosis on the index of microcirculatory resistance. Implications for the invasive assessment of microcirculatory function in ischaemic heart disease. EuroIntervention. 2017;13:944-952.

Auteurs

Hernan Mejia-Renteria (H)

Department of Cardiology, Hospital Clínico San Carlos IDISSC and Universidad Complutense de Madrid, Madrid, Spain.

Joo Myung Lee (JM)

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Ki-Hong Choi (KH)

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Seung-Hun Lee (SH)

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Lin Wang (L)

Department of Cardiology, Hospital Clínico San Carlos IDISSC and Universidad Complutense de Madrid, Madrid, Spain.

Tsunekazu Kakuta (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Bon-Kwon Koo (BK)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.
The Institute on Aging, Seoul National University, Seoul, South Korea.

Javier Escaned (J)

Department of Cardiology, Hospital Clínico San Carlos IDISSC and Universidad Complutense de Madrid, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH